The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1, open-label, dose-escalation study of olaratumab as a single agent and in combination with doxorubicin, vincristine/irinotecan, or high-dose ifosfamide in pediatric patients with relapsed or refractory solid tumors.
 
Leo Mascarenhas
Honoraria - Bayer
Consulting or Advisory Role - Bayer; Lilly (Inst)
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer; Lilly
 
Datchen Fritz Tai
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Michael William Bishop
Research Funding - Pfizer
Travel, Accommodations, Expenses - Lilly
 
Steven G. DuBois
Honoraria - Loxo
Consulting or Advisory Role - Loxo
Research Funding - Curis (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Loxo
 
Theodore Willis Laetsch
Consulting or Advisory Role - Loxo; Novartis
Research Funding - Amgen; Lilly; Merck
Travel, Accommodations, Expenses - Celgene
 
Donna Elise Levy
Employment - inVentiv Health
 
Sada Pillay
Employment - Lilly
Stock and Other Ownership Interests - Lilly